These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16784142)

  • 1. [Old burdens and new perspectives of the long-term anticoagulant therapy].
    Sas G
    Orv Hetil; 2006 May; 147(19):869-75. PubMed ID: 16784142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolism.
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandalà M; Ciccarese M; Papaldo P; Fabi A; Cognetti F
    Thromb Res; 2007; 119(4):525-9. PubMed ID: 16780933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conservative therapy of acute pelvic-leg vein thrombosis].
    Klein-Weigel P; Fraedrich G
    Zentralbl Chir; 2001 Jun; 126(6):441-4. PubMed ID: 11446064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of deep vein thrombosis.
    Couturaud F; Kearon C
    Semin Vasc Med; 2001; 1(1):43-54. PubMed ID: 15199513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.
    Koscielny J; Kiesewetter H; Jörg I; Harenberg J
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):299-307. PubMed ID: 17636192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended treatment for venous thromboembolism: how long is long enough?
    Cosmi B; Palareti G
    Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
    Pruemer J
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A; Márk L
    Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient management of anticoagulation therapy.
    du Breuil AL; Umland EM
    Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
    van den Bergh PJ; Kievit PC; Brouwer MA; Aengevaeren WR; Veen G; Verheugt FW
    Am Heart J; 2009 Mar; 157(3):532-40. PubMed ID: 19249425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of oral anticoagulation in patients with cancer.
    Bona RD; Hickey AD; Wallace DM
    Thromb Haemost; 1997 Jul; 78(1):137-40. PubMed ID: 9198143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic venous thrombosis. Long-term anticoagulation therapy? Yes.
    Haas S
    Hamostaseologie; 2006 Jan; 26(1):48-51. PubMed ID: 16444322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Levine MN; Raskob G; Beyth RJ; Kearon C; Schulman S
    Chest; 2004 Sep; 126(3 Suppl):287S-310S. PubMed ID: 15383476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic anticoagulation in the trauma patient: is it safe?
    Golob JF; Sando MJ; Kan JC; Yowler CJ; Malangoni MA; Claridge JA
    Surgery; 2008 Oct; 144(4):591-6; discussion 596-7. PubMed ID: 18847643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of low-molecular-weight heparins in the treatment and secondary prevention of cancer-associated thrombosis.
    Grande C; Caparro M
    Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):41-9. PubMed ID: 16360897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current challenges of anticoagulant treatment.
    Ginghină C; Giuşcă S; Serban M; Popescu BA; Jurcuţ R; Uscăţescu V
    Rom J Intern Med; 2007; 45(3):221-7. PubMed ID: 18333353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative bridging therapy for the at-risk patient on chronic anticoagulation.
    Spyropoulos AC
    Dis Mon; 2005; 51(2-3):183-93. PubMed ID: 15900271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.